Starlight Cardiovascular is developing much needed tools and devices to treat pediatric Congenital Heart Defects (CHDs). Approximately 1.3 million babies are born each year with a CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.
Location: United States, California, San Diego
Employees: 1-10
Total raised: $9.48M
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 05.10.2022 | Series A | $9.48M | - | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 05.10.2022 | Starlight Cardiovascular raises $9.48M to continue developme... | - | connect.or... |
| 05.10.2022 | Starlight Cardiovascular Raises $9.48M in Series A Financing | Starlight Cardiovascular is developing a medical device portfolio for an underserved pediatric popul... | finsmes.co... |
| 10.12.2021 | Prestigious annual pediatric medical device competition take... | Washington D.C., Dec. 10, 2021 (GLOBE NEWSWIRE) -- The National Capital Consortium for Pediatric Dev... | marketscre... |
| - | Starlight Cardiovascular | “Starlight Cardiovascular” | fastfounde... |